STTK

Conviction 72HealthcareScan · Thu, Sep 24, 2026

Shattuck Labs, Inc. (STTK) closed at $6.32 (-0.63%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 44, RS Rating 97, -21.6% from its 52-week high, +70.3% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

STTK$6.32-0.63%

ResistanceSupportVol 14Insider sell

Vol MA14 1.59M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Shattuck Labs, Inc.PHARMACEUTICAL PREPARATIONSwww.shattucklabs.com ↗

Price6.32

Change-0.63%

Gap-0.94%

Rel volume2.62×

Avg volume1.3M

Avg $ vol8.18M

SMA 206.48

SMA 506.99

SMA 2005.74

Price vs 50-9.55%

Price vs 200+10.12%

MA stackmixed

50/200 cross—

Supertrenddown · 6.95

RSI (14)44

MACD hist0.02

MACD crossbull · 0d

Stoch %K / %D49 / 48

ADX (14)22

+DI / −DI18 / 25

RSI divergence—

MACD divergence—

ATR %5.83%

ADR %5.10%

52w high8.06

52w low1.77

From 52w high-21.59%

Above 52w low+257.06%

New 52w highNo

SqueezeOff

Bollinger width28.72%

%B0.41

Donchian pos25.12%

Donchian high7.93

Donchian low5.78

AVWAP (52w high)6.39

vs AVWAP high-1.06%

AVWAP (52w low)5.75

vs AVWAP low+9.88%

OBV trendFlat

Chaikin MF (20)-0.02

Today vs 20d2.62×

Avg vol (14d)1.59M

Avg vol (20d)1.3M

Avg $ vol (20d)8.18M

Market cap634.3M

RS Rating97 / 99

RS 3m (vs SPY)+2.45%

RS 6m (vs SPY)-17.60%

RS line new highNo

Trend template6/8

Technical rank49.2

1 week+8.03%

1 month-21.59%

3 months+6.94%

6 months-0.78%

1 year+164.44%

YTD+70.35%

P/E-13.00

P/B3.00

P/S634.30

P/FCF-15.88

EPS-0.7000

Div yield—

ROE-23.12%

ROA-22.12%

Debt/Eq—

Current27.59

EV/EBITDA-11.94

Gross margin—

Net margin—

Rev growth-82.52%

EPS growth35.28%

Price target15.17

Target upside140.03%

Analyst ratingBuy

Institutional86.00%

Ent. value571M

Revenue0

Net income-15.15M

Gross profit—

Free cash flow-39.95M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out76.68M

Employees40

ListedFri, Oct 9, 2020

Free float53.77M

Float %71.3%

Short interest5.57M

Days to cover7.6d

Short volume70.1%

Squeeze score81 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.12 vs −$0.14

Last surprise+14.3% beat

Setup gradeB

Conviction72 / 100

Pattern quality—

Tech rank49.2 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.05

Support6.27

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jul 24 – Aug 3
2 scans
→
Breaking out now
Aug 4 – Aug 24
2 scans
→
Broke out
Aug 25
1 scan
→
Retesting breakout
Aug 26
1 scan

Congress activity

Disclosed STOCK Act trades in STTK

All disclosures →

No recent disclosed trades by Congress in STTK. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in STTK · open-market 1 sell

Insider	Side	Shares	Value	Traded	Filed
Shukla Abhinav A. Chief Technical Officer · Stock Option (Right to Buy) · 2026-07-06	Exercise	12.15K	—	2026-07-06	2026-07-07
Shukla Abhinav A. Chief Technical Officer · Common Stock · 2026-07-06	Exercise	12.15K	$43K	2026-07-06	2026-07-07
Shukla Abhinav A. Chief Technical Officer · Stock Option (Right to Buy) · 2026-07-02	Exercise	410	—	2026-07-02	2026-07-07
Shukla Abhinav A. Chief Technical Officer · Common Stock · 2026-07-02	Exercise	410	$1K	2026-07-02	2026-07-07
Shukla Abhinav A. Chief Technical Officer · Common Stock · 2026-07-02	Sell	410	$3K	2026-07-02	2026-07-07
OrbiMed Capital GP IX LLC Director · Pre-Funded Warrants (right to buy) · 2026-06-08	Convert	3.07M	—	2026-06-08	2026-06-09
OrbiMed Capital GP IX LLC Director · Common Stock · 2026-06-08	Other	—	—	2026-06-08	2026-06-09
OrbiMed Genesis GP LLC Director · Common Warrants (right to buy) · 2026-06-08	Convert	15.37M	—	2026-06-08	2026-06-09
OrbiMed Capital GP IX LLC Director · Common Warrants (right to buy) · 2026-06-08	Convert	15.37M	—	2026-06-08	2026-06-09
OrbiMed Genesis GP LLC Director · Pre-Funded Warrants (right to buy) · 2026-06-08	Convert	3.07M	—	2026-06-08	2026-06-09

SEC filings

EDGAR filings in STTK · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.